A detailed history of Krilogy Financial LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Krilogy Financial LLC holds 10,933 shares of BEAM stock, worth $273,871. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,933
Previous 51,336 78.7%
Holding current value
$273,871
Previous $1.2 Million 77.79%
% of portfolio
0.02%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$22.57 - $33.14 $911,895 - $1.34 Million
-40,403 Reduced 78.7%
10,933 $267,000
Q2 2024

Jul 22, 2024

BUY
$21.22 - $32.66 $376,315 - $579,192
17,734 Added 52.78%
51,336 $1.2 Million
Q1 2024

Apr 24, 2024

BUY
$23.46 - $45.07 $234,248 - $450,023
9,985 Added 42.28%
33,602 $1.11 Million
Q4 2023

Jan 26, 2024

BUY
$17.69 - $30.76 $417,784 - $726,458
23,617 New
23,617 $642,000

Others Institutions Holding BEAM

About Beam Therapeutics Inc.


  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.76B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.